Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe: a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT
Publication date
2024-11
Authors
Novak, Urban
Mooyaart, Jarl E
Daskalakis, Michael
Scheid, Christof
Gabellier, Ludovic
Yakoub-Agha, Ibrahim
Ram, Ron
Forcade, Edouard
López-Corral, Lucía
Nicholson, Emma
Editors
Advisors
Supervisors
Document Type
Letter
Metadata
Show full item recordCollections
License
taverne
Abstract
Keywords
Taverne, Letter
Citation
Novak, U, Mooyaart, J E, Daskalakis, M, Scheid, C, Gabellier, L, Yakoub-Agha, I, Ram, R, Forcade, E, López-Corral, L, Nicholson, E, Galli, E, Stölzel, F, Bethge, W, Wagner-Drouet, E M, Hoogenboom, J D, Mielke, S, Arber, C, Simonetta, F, Chabannon, C, Kuball, J, Ruggeri, A & Malard, F 2024, 'Choice of commercially available CAR-T cell products for r/r DLBCL & PMBCL in Europe : a survey on behalf of the cellular therapy & immunobiology working party (CTIWP) of the EBMT', Bone Marrow Transplantation, vol. 59, no. 11, pp. 1631-1634. https://doi.org/10.1038/s41409-024-02401-4